HIP, human recombinant protein
Hsc70-interacting protein, Suppression of tumorigenicity 13 protein, Putative tumor suppressor ST13,
|Calculated MW||43 kDa|
|Other Names||Hsc70-interacting protein, Suppression of tumorigenicity 13 protein, Putative tumor suppressor ST13, FAM10A1, Progesterone receptor-associated p48 protein, Renal carcinoma antigen NY-REN-33|
|Storage||-80°C; Sterile filtered liquid in 20 mM MOPS/KOH, pH 7.2, containing 250 mM KCl, 0.5 mM EDTA and 1 mM β-mercaptoethanol.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
HIP is HSP70/HSP90 Interacting Protein.
Prapapanich V.,et al.Mol. Endocrinol. 10:420-431(1996).
Mo Y.,et al.Zhonghua Zhong Liu Za Zhi 18:241-243(1996).
Cao J.,et al.J. Cancer Res. Clin. Oncol. 123:447-451(1997).
Kim J.W.,et al.Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
Collins J.E.,et al.Genome Biol. 5:R84.1-R84.11(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.